FDA Releases Alexion Pharmaceuticals Inc. Response to 483 Report

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

In a rare move, the FDA has publically released Alexion Pharmaceuticals’ response to a Form 483 following inspection of its US site and the discovery of microbial contamination.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC